AAV-Dmd CRISPR

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING
EP 3180034 A4申请人: UNIV TEXAS优先权: 2014
CN
EP
US
WO
5 件公开
PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CPF1-MEDIATED GENE EDITING
EP 3545090 A1申请人: UNIV TEXAS优先权: 2016
CN
EP
US
WO
4 件公开
COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY
- EP 3893940 A1
  申请人: SOLIDUS BIOSCIENCES INC优先权: 2018
  CN
  EP
  US
  WO
  4 件公开
- WO 2021142435 A8
  申请人: SOLID BIOSCIENCES INC优先权: 2020
  WO
DMD REPORTER MODELS CONTAINING HUMANIZED DUSCHENE MUSCULAR DYSTROPHY MUTATIONS
EP 3551752 A1申请人: UNIV TEXAS优先权: 2016
EP
US
WO
3 件公开
PRODUCTS AND METHODS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES USING CRISPR-CAS9 TO CORRECT DMD EXON DUPLICATIONS
EP 4301462 A1申请人: RES INST NATIONWIDE CHILDRENS HOSPITAL优先权: 2021
EP
US
WO
3 件公开
一种用于治疗杜氏肌营养不良症的gRNA、表达载体、CRISPR-Cas9系统
CN 110760511 B申请人: 广东赤萌医疗科技有限公司优先权: 2018
CN
针对DMD基因5号外显子突变的sgRNA及载体和应用
CN 115806989 B申请人: 昆明理工大学优先权: 2022
CN